Inhibition of HIF-1α activity by BP-1 ameliorates adjuvant induced arthritis in rats

Biochemical and Biophysical Research Communications

Volumn 387, Issue 2, 2009, Pages 223-228

  Shankar, J ^a   Thippegowda, P B ^b   Kanum, S A ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF MYSORE   (India)

Author keywords

AIA; BP 1; HIF 1 ; RA; VEGF

Indexed keywords

2 BENZOYLPHENOXYACETAMIDE; ANTIRHEUMATIC AGENT; BENZOPHENONE DERIVATIVE; BP 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; 2 BENZOYL PHENOXY ACETAMIDE; 2-BENZOYL-PHENOXY ACETAMIDE; ACETAMIDE DERIVATIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIUM CELL; GENE REPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; RAT; RHEUMATOID ARTHRITIS; ACTIVE TRANSPORT; ANIMAL; ARTHRITIS; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); RAT STRAIN;

ANIMALIA; RATTUS;

ACETAMIDES; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED STRAINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68049125934     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.086     Document Type: Article

References (33)

1. Doan T., and Massarotti E. Rheumatoid arthritis: an overview of new and emerging therapies. J. Clin. Pharmacol. 45 (2005) 751-762
2. Walsh D.A. Angiogenesis and arthritis. Rheumatology (Oxford) 38 (1999) 103-112
3. Koch A.E. Angiogenesis as a target in rheumatoid arthritis. Ann. Rheum. Dis. 62 (2003) 60-67
4. Fava R.A., Olsen N.J., Spencer-Green G., Yeo K.T., Yeo T.K., Berse B., Jackman R.W., Senger D.R., Dvorak H.F., and Brown L.F. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180 (1994) 341-346
5. Pufe T., Petersen W., Tillmann B., and Mentlein R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum. 44 (2001) 1082-1088
6. Latour F., Zabraniecki L., Dromer C., Brouchet A., Durroux R., and Fournie B. Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? Clinical, radiological, and pathological study in 12 patients monitored for 10 years. Joint Bone Spine 68 (2001) 493-498
7. Clavel G., Bessis N., Lemeiter D., Fardellone P., Mejjad O., Menard J.F., Pouplin S., Boumier P., Vittecog O., Le Loet X., and Boissier M.C. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin. Immunol. 124 (2007) 158-164
8. Stevens C.R., Blake D.R., Merry P., Revell P.A., and Levick J.R. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum. 34 (1991) 1508-1513
9. Steinbrech D.S., Longaker M.T., Mehrara B.J., Saadeh P.B., Chin G.S., Gerrets R.P., Chau D.C., Rowe N.M., and Gittes G.K. Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation. J. Surg. Res. 84 (1999) 127-133
10. Hollander A.P., Corke K.P., Freemont A.J., and Lewis C.E. Expression of hypoxia inducible factor 1 by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44 (2001) 1540-1544
11. Hitchon C., Wong K., Ma G., Reed J., Lyttle D., and El-Gabalawy H. Hypoxia induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum. 46 (2002) 2587-2597
12. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.P., Ferrara N., and Johnson R.S. HIF-1 is essential for myeloid cell-mediated inflammation. Cell 112 (2003) 645-657
13. Brucker P.U., Izzo N.J., and Chu C.R. Tonic activation of hypoxia-inducible factor 1 in avascular articular cartilage and implications for metabolic homeostasis. Arthritis Rheum. 52 (2005) 3181-3191
14. Hitchon C.A., and El-Gabalawy H.S. Oxidation in rheumatoid arthritis. Arthritis Res. Ther. 6 (2004) 265-278
15. Gaber T., Dziurla R., Tripmacher R., Burmester G.R., and Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!. Ann. Rheum. Dis. 64 (2005) 971-980
16. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor-1. Mol. Cell. Biol. 16 (1996) 4604-4613
17. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., and Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia inducible factor-1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA 94 (1997) 4273-4278
18. Henry Jacobs G.E., Carrington C.M.S., McLean S., and Freeholds W. Prenylated benzophenone derivatives from Caribbean Clusia species (Guttiferae). Plukenetiones B-G and xerophenone A. Tetrahedron 55 (1999) 1581-1596
19. Karrer F., Meier H., and Pascual A. Short synthesis of 4-chloro-4-(chlorodifluoromethoxy) benzophenone. J. Flour. Chem. 103 (2000) 81-84
20. Sheu S.Y., Tsai H.J., and Chiang H.C. Benzophenones as xanthine oxidase inhibitors. Anticancer Res. 19 (1999) 1131-1135
21. Prabhakar B.T., Khanum S.A., Jayashree K., Salimath B.P., and Shashikanth S. Anti-tumor and proapoptotic effect of novel synthetic benzophenone analogues in Ehrlich ascites tumor cells. Bioorg. Med. Chem. 14 (2006) 435-446
22. Khanum S.A., Shashikanth S., and Deepak A.V. Synthesis and anti-inflammatory activity of benzophenone analogues. Bioorg. Med. Chem. 32 (2004) 211-222
23. Prabhakar B.T., Khanum S.A., Shashikanth S., and Salimath B.P. Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1α and down regulation of VEGF of in-vivo. Invest. New Drugs 24 (2006) 471-478
24. Drumond D.C., and Glynn L.E. The production of arthritis in rabbits by immunological reaction to fibrin. Br. J. Exp. Pathol. 43 (1962) 380-473
25. Joe B., Ummiti Rao J.S.P., and Lokesh B.R. Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Mol. Cell. Biochem. 169 (1997) 125-134
26. McEvoy A.N., Murphy E.A., Ponnio T., Conneely O.M., Bresnihan B., FitzGerald O., and Murphy E.P. Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5′-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue. J. Immunol. 168 (2002) 2979-2987
27. Lu J., Kasama T., Kobayashi K., Yoda Y., Shiozawa F., Hanyuda M., Negishi M., Ide H., and Adachi M. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J. Immunol. 164 (2000) 5922-5927
28. Ottosen E.R., Sorensen M.D., Bjorkling F., Skak-Nielsen T., Fjording M.S., Aaes H., and Binderup L. Synthesis and structure-activity relationship of aminobenzophenones. A novel class of p38 MAP kinase inhibitors with high anti-inflammatory activity. J. Med. Chem. 46 (2003) 5651-5662
29. Welstead W.J., Moran H.W., Stauffer H.F., Turnbull L.B., and Sancilio L.F. Anti-inflammatory agents. 1. Synthesis and anti-inflammatory activity of 2-amino-3-benzoylphenylacetic acid. J. Med. Chem. 46 (1979) 1074-1079
30. Sone H., Kawakami Y., Sakauchi M., Nakamura Y., Takahashi A., Shimano H., Okuda Y., Segawa T., Suzuki H., and Yamada N. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem. Biophys. Res. Commun. 281 (2001) 562-568
31. Khong T.L., Larsen H., Raatz Y., and Paleolog E.M. Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experience. Angiogenesis 10 (2007) 243-258
32. Kurosaka D., Yoshida K., Yasuda J., Yokoyama T., Kingetsu I., Yamaguchi N., Joh K., Matsushima M., Saito S., and Yamada A. Inhibition of arthritis by systemic administration of endostatin in passive murine collagen induced arthritis. Ann. Rheum. Dis. 62 (2003) 677-679
33. Peters C.L., Morris C.J., Mapp P.I., Blake D.R., Lewis C.E., and Winrow V.R. The transcription factors hypoxia-inducible factor 1 and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum. 50 (2004) 291-296